Our Science

Advancing Cancer Treatment Using a Precision Approach using Tumor Genetics & Microbiome modulation.

Pairing treatment with information on tumor genetics and microbiome profile

Using microbiome as an adjunct flexible metabolic tool to improve treatment efficacy and qualify of life of cancer patients

Microbiome and Cancer

Commensal microbes are found in tumor tissue itself, normal tissue adjacent to tumor and at tumor sites such as the gut, genitourinary tract and airway, with overlap between these sites. Microorganisms within, adjacent to and distant from the tumor may play a role in cancer development and progression, and interactions and differences between these microbial populations, with their associated molecules and molecular pathways, have the potential to
influence the course of disease

The microbiome of humans contains trillions of organisms distributed throughout the body. These organisms and their collective genomes – the human commensal microbiome – develops from birth, with influence from both the maternal microbiota and the environment, and varies between individuals due to the cumulative effects of host factors and environmental exposures

The human microbiome is an emerging target in cancer development and therapeutics. It may be directly oncogenic, through promotion of mucosal inflammation or systemic dysregulation, or may alter anticancer immunity/therapy.

Dysbiosis or disruption of the normal commensal microbiota is associated with a wide range of diseases, including inflammatory bowel disease, multiple sclerosis, obesity, autism, depression, cardiovascular disease and allergy, as well as cancer.

The microbiome has been implicated in cancer in a variety of specific ways, including being directly oncogenic, through promotion of oncogenic mucosal inflammation or systemic metabolic/immune dysregulation and through modulation of anti-cancer immunity or the efficacy of anti-cancer therapy

Designer microbiome

At CareBiom, we have developed specific strains and prebiotics technology using our BiomsifyTM Technology to create designer commensal with specific funcational characteristics

Microbiome Modulation

Our metagenomic-biomarker analysis, patented fermentation technology, and microbiome modulating synbiotic combinations allow us to modulate the commensal flora for enhancing cancer therapeutic efficacy and post treatment care programs

Microbiome Biobanking & metagenomics

Our microbiome analysis and storage services for cancer patients focused on novel insights on microbiome composition and metabolic profile that helps with cancer treatment and long-term care

Our Technology Platform

Our platform technologies are focused around analyzing and modulating commensal microflora and metabolic profile

Designer microbiome

At CareBiom, we have developed specific strains and prebiotics technology using our BiomsifyTM Technology to create designer commensal with specific funcational characteristics

Microbiome Modulation

Our metagenomic-biomarker analysis, patented fermentation technology, and microbiome modulating synbiotic combinations allow us to modulate the commensal flora for enhancing cancer therapeutic efficacy and post treatment care programs

Microbiome Biobanking & metagenomics

Our microbiome analysis and storage services for cancer patients focused on novel insights on microbiome composition and metabolic profile that helps with cancer treatment and long-term care

Our Technology Platform

Our platform technologies are focused around analyzing and modulating commensal microflora and metabolic profile